Venous thromboembolism in children with cystic fibrosis: Retrospective incidence and intrapopulation risk factors. Issue 158 (October 2017)

• Record Type: Journal Article
• Authors: Knight-Perry, Jessica; Branchford, Brian R.; Thornhill, Dianne; Martiniano, Stacey L.; Sagel, Scott D.; Wang, Michael
• Is Part Of: Thrombosis research. Issue 158(2017)
• Page Start: 161
• Page End: 166
• Publication Date: 2017-10
• Subjects: Pediatric -- Venous thromboembolism -- Risk stratification -- Cystic fibrosis; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2017.08.022
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: Introduction: Pediatric venous thromboembolism (VTE) is a rare but serious medical condition. Cystic fibrosis (CF) is a risk for recurrent pediatric VTE and has potential thrombophilic tendency. However, much remains unknown, including incidence and intrapopulation risk factors. Methods: A retrospective cohort of pediatric CF patients followed at Children's Hospital Colorado from January 1st 2003 through May 20th 2016 was examined. Cases were identified by informatics and validated manually. Data on CF severity, co-morbidities and treatment, central venous catheter (CVC) use, and thrombophilia were obtained from an institutional CF database and chart review. Results: Nineteen VTE occurred in 458 participants followed for 3595 person-years, yielding an incidence rate of 53 VTE per 10, 000 children with CF. VTE cases had additional co-morbidities including CF-related diabetes ( p = 0.002) and sinus disease ( p = 0.04), more total admissions ( p < 0.001), admit days (p < 0.001), positive respiratory cultures (p < 0.001), pseudomonas infections ( p < 0.001), steroid courses ( p = 0.001), and total CVC days (PICC p = 0.03, port p = 0.007). On univariate analysis, older age (RR 1.162, p = 0.007), sinus disease (RR 2.62, p = 0.05), longer hospital stay (RR 1.03, p < 0.001), higher ESR (RR 1.02, p = 0.03) and CRP (RR 1.07, p = 0.007), and an absence of systemic steroids (RR 0.19, p = 0.004) increased the risk of VTE. Conclusions: In this cohort, children with CF had a higher incidence of VTE when compared to the previously reported incidence in the overall pediatric population at Children's Hospital Colorado. Overall, those with VTE had a greater disease burden and older age, sinus disease, longer hospitalization and increased inflammation were VTE risk factors. Highlights: A retrospective cohort of children with cystic fibrosis was followed from 2003–2016. 28 total thrombi and 19 venous thromboemboli (VTE) were diagnosed in 458 children. The incidence rate was 53 VTE and 42 hospital-acquired VTE per 10, 000 children. Children with a VTE diagnosis had greater cystic fibrosis disease burden. Older age, sinus disease, longer hospital stay and inflammation increased VTE risk.